World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
51
Citations
9881
World Ranking
13892
National Ranking
2155

Peng Zhan publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Peng Zhan sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 292 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Peng Zhan D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Peng Zhan sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 51 D-Index — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Peng Zhan is affiliated with Shandong University in China, contributing extensively to research in medicine and biochemistry, genetics, and molecular biology. Their work spans several key subfields, including infectious diseases, molecular biology, virology, epidemiology, and organic chemistry.

The primary research topics addressed by Peng Zhan include:

  • HIV/AIDS drug development and treatment
  • HIV research and treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Computational drug discovery methods
  • Click chemistry and applications
  • Hepatitis C virus research
  • SARS-CoV-2 and COVID-19 research

Peng Zhan has published numerous papers in well-known scientific venues. Frequent publication venues encompass:

  • Journal of Medicinal Chemistry (35 publications)
  • European Journal of Medicinal Chemistry (23 publications)
  • Chinese Chemical Letters (11 publications)
  • Drug Discovery Today (6 publications)
  • Bioorganic & Medicinal Chemistry (6 publications)

Among recent papers authored or co-authored by Peng Zhan are:

  • "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling," 2020, Signal Transduction and Targeted Therapy
  • "Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities," 2020, Journal of Medicinal Chemistry
  • "Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses," 2021, Chemical Society Reviews
  • "SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules," 2022, Signal Transduction and Targeted Therapy
  • "Recent developments in the medicinal chemistry of single boron atom-containing compounds," 2021, Acta Pharmaceutica Sinica B

Peng Zhan frequently collaborates with several co-authors in their field, including:

  • Xinyong Liu
  • Dongwei Kang
  • Christophe Pannecouque
  • Erik De Clercq
  • Shujing Xu

In addition to journal publications, Peng Zhan has contributed to book publications. Notably, a title published by Springer Nature is "Antiviral Drug Discovery and Development" (2021), which has received citations.

Best Publications

  • Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends

    Peng Zhan;Christophe Pannecouque;Erik De Clercq;Xinyong Liu

  • Conformational restriction: an effective tactic in 'follow-on'-based drug discovery

    Zengjun Fang;Yu'ning Song;Peng Zhan;Qingzhu Zhang

  • 8-Hydroxyquinoline: a privileged structure with a broad-ranging pharmacological potential

    Yu'ning Song;Hao Xu;Wenmin Chen;Peng Zhan

  • Recent applications of click chemistry in drug discovery.

    Xiangyi Jiang;Xia Hao;Lanlan Jing;Gaochan Wu

  • Current drug research on PEGylation with small molecular agents

    Wenjun Li;Peng Zhan;Erik De Clercq;Hongxiang Lou

  • Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities.

    Siyu Xiu;Alexej Dick;Han Ju;Sako Mirzaie

  • Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries.

    Xueshun Wang;Boshi Huang;Xinyong Liu;Peng Zhan

  • The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic

    Vigneshwaran Namasivayam;Murugesan Vanangamudi;Victor G. Kramer;Sonali Kurup

  • Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles.

    Dongwei Kang;Zengjun Fang;Zhenyu Li;Boshi Huang

  • Overview of Recent Strategic Advances in Medicinal Chemistry

    Gaochan Wu;Tong Zhao;Dongwei Kang;Jian Zhang

  • Strategies for the Design of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Lessons from the Development of Seven Representative Paradigms

    Dongyue Li;Peng Zhan;Erik De Clercq;Xinyong Liu

  • Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses

    Yue Ma;Estrella Frutos-Beltrán;Dongwei Kang;Christophe Pannecouque

  • 1,3,4-Oxadiazole: A Privileged Structure in Antiviral Agents

    Z. Li;P. Zhan;X. Liu

  • Recent advances in DAPYs and related analogues as HIV-1 NNRTIs.

    Xuwang Chen;Peng Zhan;Dongyue Li;Erik De Clercq

  • Design Strategies of Novel NNRTIs to Overcome Drug Resistance

    Peng Zhan;Xinyong Liu;Zhenyu Li;Christophe Pannecouque

  • Recent developments in the medicinal chemistry of single boron atom-containing compounds

    Shu Song;Ping Gao;Lin Sun;Dongwei Kang

  • Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants

    Dongwei Kang;Zengjun Fang;Boshi Huang;Xueyi Lu

  • Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: Optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches

    Boshi Huang;Cuicui Li;Wenmin Chen;Tao Liu

  • Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies

    Peng Zhan;Xinyong Liu;Zhenyu Li;Zengjun Fang

  • Identification of the KDM2/7 histone lysine demethylase subfamily inhibitor and its antiproliferative activity.

    Takayoshi Suzuki;Hiroki Ozasa;Yukihiro Itoh;Peng Zhan

  • Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus.

    Ye Tian;Zhaoqiang Liu;Jinghan Liu;Boshi Huang

  • Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: Design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives

    Ye Tian;Deping Du;Diwakar Rai;Liu Wang

  • Identification of Highly Selective and Potent Histone Deacetylase 3 Inhibitors Using Click Chemistry-Based Combinatorial Fragment Assembly

    Takayoshi Suzuki;Takayoshi Suzuki;Yuki Kasuya;Yukihiro Itoh;Yosuke Ota

  • Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles.

    Boshi Huang;Wenmin Chen;Tong Zhao;Zhenyu Li

  • 1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

    Peng Zhan;Xinyong Liu;Yuan Cao;Yan Wang

Frequent Co-Authors

Xinyong Liu
Xinyong Liu Shandong University
Erik De Clercq
Erik De Clercq Rega Institute for Medical Research
Christophe Pannecouque
Christophe Pannecouque Rega Institute for Medical Research
Jan Balzarini
Jan Balzarini KU Leuven
Luis Menéndez-Arias
Luis Menéndez-Arias Spanish National Research Council
Takayoshi Suzuki
Takayoshi Suzuki Osaka University
Chin Ho Chen
Chin Ho Chen Duke University
Kuo Hsiung Lee
Kuo Hsiung Lee University of Minnesota
Hong Liu
Hong Liu Shandong University
Jacob Kongsted
Jacob Kongsted University of Southern Denmark

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to various innovative and impactful career paths, many of which intersect with forensic science and criminal justice. For those interested in hands-on technical roles, becoming an autopsy technician is a specialized option involving the preparation and analysis of medical examiner cases.

Many students choose to advance their knowledge through a forensic degree online, combining chemistry with criminal investigation techniques. These programs offer flexibility and affordability, making it easier to gain relevant expertise without interrupting your career.

For those aiming to delve deeper into the psychological aspects of forensics, pursuing a masters in forensic psychology online can enhance your understanding of human behavior and improve your analytical skills, which are crucial in many forensic careers.

Career prospects in forensic science remain promising, with competitive compensation for qualified professionals. Exploring the forensic scientist salary and job outlook can help you make informed decisions about your educational path and career goals in this dynamic field.

Best Scientists Citing Peng Zhan

Trending Scientists

Recently Published Articles